
Insight
Build, Buy or Partner: How to Spend a 2027 Digital Health Budget
The AI label now carries a 16% funding discount and acquired ventures average 10.7 years old. How to choose between building, buying and partnering in 2027.
Topic archive
Galen Growth analysis of digital health partnerships, strategic collaboration, and market activity.
View all insights
Insight
The AI label now carries a 16% funding discount and acquired ventures average 10.7 years old. How to choose between building, buying and partnering in 2027.

Insight
Pharma holds 1,707 Digital Health partnerships across 13 portfolios — a measurable asset investors ignore. Novartis converts 31% to evidence grade; Bayer 18%.

Insight
Hinge Health paid $105M for Cylinder Health, but the deal adds just $7–8M in 2026 revenue — Galen Growth's analysis of the platform-building logic behind it.

Insight
Partnerships fell 20% vs a 37% funding deal decline in H1 2026. Galen Growth’s definitive read on why partnerships now signal digital health demand.

Insight
Akili merges with Virtual Therapeutics in a go-private deal to create a larger, diversified digital mental health company.

Insight
Evaluate and Galen Growth announced a commercial partnership to bring HealthTech Alpha to a broader market.